Literature DB >> 15114052

Gene expression profiling: from microarrays to medicine.

Ashani T Weeraratna1, James E Nagel, Valeria de Mello-Coelho, Dennis D Taub.   

Abstract

With the mapping of the human genome comes the ability to identify genes of interest in specific diseases and the pathways involved therein. Laboratory technology has evolved in parallel, providing us with the ability to assay thousands of these genes at once, a technique known as microarray analysis. The main question that this type of technology raises is how we can apply this powerful technology to clinical medicine. Recently, advances in data analysis, as well as standardization of the technology, have allowed us to examine this question, and indeed a few clinical trials currently being performed include microarrays as part of their protocol. In this review we outline the microarray technique and describe these types of studies in further detail.

Entities:  

Mesh:

Year:  2004        PMID: 15114052      PMCID: PMC7086522          DOI: 10.1023/B:JOCI.0000025443.44833.1d

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  94 in total

1.  Informatic selection of a neural crest-melanocyte cDNA set for microarray analysis.

Authors:  S K Loftus; Y Chen; G Gooden; J F Ryan; G Birznieks; M Hilliard; A D Baxevanis; M Bittner; P Meltzer; J Trent; W Pavan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Normalization strategies for cDNA microarrays.

Authors:  J Schuchhardt; D Beule; A Malik; E Wolski; H Eickhoff; H Lehrach; H Herzel
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

3.  Stereotyped and specific gene expression programs in human innate immune responses to bacteria.

Authors:  Jennifer C Boldrick; Ash A Alizadeh; Maximilian Diehn; Sandrine Dudoit; Chih Long Liu; Christopher E Belcher; David Botstein; Louis M Staudt; Patrick O Brown; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays.

Authors:  J B Fan; X Chen; M K Halushka; A Berno; X Huang; T Ryder; R J Lipshutz; D J Lockhart; A Chakravarti
Journal:  Genome Res       Date:  2000-06       Impact factor: 9.043

5.  CYP2D6 genotyping with oligonucleotide microarrays and nortriptyline concentrations in geriatric depression.

Authors:  G M Murphy; B G Pollock; M A Kirshner; N Pascoe; W Cheuk; B H Mulsant; C F Reynolds
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

6.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

7.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

8.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray.

Authors:  J David Barrans; Paul D Allen; Dimitrios Stamatiou; Victor J Dzau; Choong-Chin Liew
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

10.  CLUSFAVOR 5.0: hierarchical cluster and principal-component analysis of microarray-based transcriptional profiles.

Authors:  Leif E Peterson
Journal:  Genome Biol       Date:  2002-06-24       Impact factor: 13.583

View more
  8 in total

1.  How to improve quality assurance in fluorometry: fluorescence-inherent sources of error and suited fluorescence standards.

Authors:  U Resch-Genger; K Hoffmann; W Nietfeld; A Engel; J Neukammer; R Nitschke; B Ebert; R Macdonald
Journal:  J Fluoresc       Date:  2005-05       Impact factor: 2.217

2.  Current and emerging technology approaches in genomics.

Authors:  Yvette P Conley; Leslie G Biesecker; Stephen Gonsalves; Carrie J Merkle; Maggie Kirk; Bradley E Aouizerat
Journal:  J Nurs Scholarsh       Date:  2013-01-07       Impact factor: 3.176

Review 3.  Biomarkers for the development of cancer vaccines: current status.

Authors:  John Copier; Mike Whelan; Angus Dalgleish
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

4.  Transcriptome analysis of age-, gender- and diet-associated changes in murine thymus.

Authors:  Ana Lustig; Ashani T Weeraratna; William W Wood; Diane Teichberg; Dorothy Bertak; Arnell Carter; Suresh Poosala; Jeffrey Firman; Kevin G Becker; Alan B Zonderman; Dan L Longo; Dennis D Taub
Journal:  Cell Immunol       Date:  2007-05-17       Impact factor: 4.868

5.  Transcriptome characterization by RNA-Seq reveals the involvement of the complement components in noise-traumatized rat cochleae.

Authors:  M Patel; Z Hu; J Bard; J Jamison; Q Cai; B H Hu
Journal:  Neuroscience       Date:  2013-05-30       Impact factor: 3.590

6.  Dissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers.

Authors:  Brian Dean
Journal:  Schizophr Res Treatment       Date:  2011-06-18

7.  Gene network analyses point to the importance of human tissue kallikreins in melanoma progression.

Authors:  Waleska K Martins; Gustavo H Esteves; Otávio M Almeida; Gisele G Rezze; Gilles Landman; Sarah M Marques; Alex F Carvalho; Luiz F L Reis; João P Duprat; Beatriz S Stolf
Journal:  BMC Med Genomics       Date:  2011-10-27       Impact factor: 3.063

Review 8.  Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology.

Authors:  Anatoliy Gladkevich; S Adriaan Nelemans; Henk F Kauffman; Jakob Korf
Journal:  Mediators Inflamm       Date:  2005-12-14       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.